Cromos Pharma’s Strategic Meeting in Miami
Last week, Cromos Pharma US executive team gathered in Miami for a full-day strategy session. This meeting was aimed at reinforcing our collaborative spirit and refining our business approaches. More than just a conventional meeting, it was a great chance for our team members to build stronger bonds and share important ideas We wrapped up
Happy Easter 2024
May this Easter bring health, hope, and success to you and your loved ones. Wishing you a joyful celebration from all of us at Cromos Pharma.
Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor
The FDA has given the green light to the Dexcom Stelo Glucose Biosensor System, the first of its kind continuous glucose monitor (CGM) that will be available directly to consumers. Slated for release in summer 2024, this innovative device offers adults over 18 who do not rely on insulin a novel way to monitor their
